[Symptomatic infantile polymyoclonus].
D000293:Adolescent; D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use; D001552:Benzazepines / Q000627:therapeutic use; D001933:Brain Stem / Q000473:pathology; D002524:Cerebellar Ataxia / Q000209:etiology; D002648:Child; D003520:Cyclophosphamide / Q000627:therapeutic use; D005133:Eye Movements; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D008479:Mediastinal Neoplasms / Q000150:complications* / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery; D008590:Meningoencephalitis / Q000150:complications*; D009207:Myoclonus / Q000188:drug therapy / Q000209:etiology*; D009447:Neuroblastoma / Q000150:complications* / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery; D014750:Vincristine / Q000627:therapeutic use
D001552:Benzazepines; D014750:Vincristine; D003520:Cyclophosphamide; D000324:Adrenocorticotropic Hormone
Symptomatische infantile Polymyoklonie.